EUVIMEDOpdag EUVIMED
Crossref

Shortening the perioperative prophylactic antimicrobial duration in pediatric ventriculoperitoneal ( VP ) shunt insertion

Ayumi Tada iD, Satoshi Ihara, Junichi Suwa, Hanako Funakoshi iD, Yuho Horikoshi

Pediatrics International · 2026-01 · 68 (1)

DOI: 10.1111/ped.70372 ↗

At a glance

Journal article in Pediatrics International, published online on 2026-03-22. Written by Ayumi Tada and 4 co-authors. Institution: Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan. Major MEDLINE topics: Ventriculoperitoneal Shunt, Antibiotic Prophylaxis, Central Nervous System Infections, Anti-Bacterial Agents. 25 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Perioperative antimicrobial therapy is important to prevent central nervous system (CNS) infections following cerebrospinal fluid (CSF) shunt insertion, but the optimal duration remains unclear. This study aimed to evaluate the incidence of ventriculoperitoneal (VP) shunt‐associated CNS infection before and after the revision of the institutional protocol for discontinuing antimicrobial therapy within 48 h after surgery.

Methods

Patients aged 15 years or less who underwent VP shunt insertion at Tokyo Metropolitan Children's Medical Center between April 2014 and November 2021 were enrolled retrospectively. The primary outcome was the incidence of VP shunt‐associated CNS infection at postoperative months 1 and 6 in pre‐ and post‐intervention patient groups.

Results

Of the 117 patients screened, 27 were excluded. Of the eligible patients, 39 were in the pre‐intervention group, and 51 were in the post‐intervention group. The incidence of VP shunt‐associated CNS infection at month 1 was 7.7% (3/39) in the pre‐intervention group and 7.8% (4/51) in the post‐intervention group ( p = 0.98), with no significant difference. At month 6, the incidence was 7.7% (3/39) in the pre‐intervention group and 13.7% (7/51) in the post‐intervention group ( p = 0.37), also not significantly different.

Conclusions

Reducing the duration of antibiotic prophylaxis for VP shunt insertion to within 48 h did not increase the incidence of VP shunt‐associated CNS infection.

Subjects

MeSH terms (MEDLINE)

Ventriculoperitoneal ShuntAntibiotic ProphylaxisCentral Nervous System InfectionsAnti-Bacterial AgentsPerioperative CareHumansFemaleRetrospective StudiesIncidenceMaleChild, PreschoolChildInfantAdolescent

Author keywords

antibiotic stewardshipdurationpediatricsprophylactic antibioticshunt infection

Substances

Anti-Bacterial Agents

Authors and institutions

  • Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Department of Pharmacy, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

ORCID profiles: Ayumi Tada, Hanako Funakoshi

Cite

APA

Tada, A., Ihara, S., Suwa, J., Funakoshi, H., & Horikoshi, Y. (2026). Shortening the perioperative prophylactic antimicrobial duration in pediatric ventriculoperitoneal ( VP ) shunt insertion. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70372

Vancouver

Tada A, Ihara S, Suwa J, Funakoshi H, Horikoshi Y. Shortening the perioperative prophylactic antimicrobial duration in pediatric ventriculoperitoneal ( VP ) shunt insertion. Pediatrics International. 2026;68(1). doi:10.1111/ped.70372

BibTeX
@article{Tada2026,
  author = {Tada, Ayumi and Ihara, Satoshi and Suwa, Junichi and Funakoshi, Hanako and Horikoshi, Yuho},
  title = {Shortening the perioperative prophylactic antimicrobial duration in pediatric ventriculoperitoneal ( VP ) shunt insertion},
  journal = {Pediatrics International},
  year = {2026},
  volume = {68},
  number = {1},
  doi = {10.1111/ped.70372}
}
Start for free →